Bumin Hospital Group and Inocraskorea Sign Business Agreement in Whole Genome Sequencing Field

Joint Collaboration in Whole Genome Sequencing, Precision Diagnosis, and AI Platform Development

Bumin Hospital Group and Inocraskorea signed a business agreement on August 26 at the Bumin Prestige Lifecare Center to advance the field of whole genome sequencing.

Bumin Hospital Group is signing a business agreement with Inocraskorea to advance the field of whole genome sequencing. Provided by Bumin Hospital Group

The signing ceremony was attended by Jung Hoonjae, Director of Research at Bumin Hospital Group, Lee Jeongseok, CEO of Inocraskorea, and other officials from both organizations.

Under the agreement, the two parties will pursue multifaceted cooperation, including: supporting the successful operation of the Bumin Prestige Lifecare Center; strategic collaboration in the field of whole genome sequencing analysis; developing an AI platform for precision diagnosis and personalized treatment of cancer and rare diseases; and conducting joint research and sharing results based on clinical data.

Through this agreement, Bumin Hospital Group plans to strengthen precision medicine and next-generation AI-based medical services, aiming to provide new solutions in the diagnosis of rare diseases and cancer. By combining Inocraskorea’s advanced genome analysis technology, the group seeks to innovate patient-specific diagnostic and treatment services.

Jung Hoonjae, Director of Research, stated, "This agreement marks a meaningful starting point for realizing patient-centered future medicine," adding, "We will take the lead in the fields of precision diagnosis and personalized treatment."

Lee Jeongseok, CEO, also emphasized, "We will integrate clinical data and genome analysis capabilities into medical practice to achieve world-class results."

The two organizations plan to establish concrete implementation measures through close consultation and actively promote joint projects that will contribute to the development of the domestic and global healthcare industry.

This content was produced with the assistance of AI translation services.